Odiparcil

Generic Name: Odiparcil

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₁₅H_₁₆O_₆S

CAS Number: 137215-12-4

Unique Ingredient Identifier: FIK1414ZI8

Indication: Investigated for use/treatment in atrial fibrillation, cardiovascular disorders, thrombosis, and venous thromboembolism.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Inventiva announces Filing of 2024 Half-Year Report

Inventiva filed its 2024 Half-Year Report with the AMF, noting material uncertainty related to its going concern status. The report is available on Inventiva's and AMF's websites. Inventiva focuses on developing oral therapies for MASH/NASH and other unmet medical needs, with lanifibranor in pivotal Phase III trial for MASH/NASH.

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy